Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

3 source entries across 3 studies. This list may not include all unresolved or historical entries.

  • ALGRX 3268Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • ALGRX 3268Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • ALGRX 3268Registry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2
1
33%
Phase 3
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 32 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_3

Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.

NCT00146185
completedphase_2

Study of ALGRX 3268 for Needlestick Pain in Children

NCT00132405
completedphase_3

Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.

NCT00140088

Clinical Trials (3)

Showing 3 of 3 trials
NCT00146185Phase 3

Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.

Completed
NCT00132405Phase 2

Study of ALGRX 3268 for Needlestick Pain in Children

Completed
NCT00140088Phase 3

Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.

Completed

All 3 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
3